Janus Henderson Group PLC Vertex Pharmaceuticals Inc Transaction History

Janus Henderson Group PLC

$182 Billion
Q2 2024

A detailed history of Janus Henderson Group PLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Janus Henderson Group PLC holds 2,416,717 shares of VRTX stock, worth $1.21 Billion. This represents 0.62% of its overall portfolio holdings.

Number of Shares

2,416,717

Previous 2,584,315 6.49%

Holding current value

$1.21 Billion

Previous $1.08 Billion 4.86%

% of portfolio

0.62%

Previous 0.61%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$392.81 - $485.53 $65.8 Million - $81.4 Million	-167,598 Reduced 6.49%	2,416,717 $1.13 Billion
Q1 2024 May 15, 2024	BUY	$407.69 - $446.08 $99.6 Million - $109 Million	244,336 Added 10.44%	2,584,315 $1.08 Billion
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $234 Million - $280 Million	681,156 Added 41.06%	2,339,979 $952 Million
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $75.7 Million - $81.2 Million	223,905 Added 15.6%	1,658,823 $577 Million
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $21.4 Million - $24 Million	68,206 Added 4.99%	1,434,918 $505 Million
Q1 2023 May 15, 2023	SELL	$283.23 - $323.1 $5.31 Million - $6.06 Million	-18,764 Reduced 1.35%	1,366,712 $431 Million
Q4 2022 Feb 14, 2023	SELL	$285.76 - $321.48 $33.2 Million - $37.3 Million	-116,059 Reduced 7.73%	1,385,476 $400 Million
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $37.6 Million - $42 Million	-137,417 Reduced 8.38%	1,501,535 $435 Million
Q2 2022 Aug 15, 2022	SELL	$234.96 - $292.55 $39.2 Million - $48.8 Million	-166,647 Reduced 9.23%	1,638,952 $462 Million
Q1 2022 May 16, 2022	SELL	$221.42 - $260.97 $41 Million - $48.3 Million	-185,141 Reduced 9.3%	1,805,599 $471 Million
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $25.5 Million - $32.2 Million	-144,038 Reduced 6.75%	1,990,740 $437 Million
Q3 2021 Nov 16, 2021	SELL	$181.39 - $202.99 $391 Million - $437 Million	-2,153,680 Reduced 50.22%	2,134,778 $387 Million
Q2 2021 Aug 16, 2021	SELL	$187.49 - $221.1 $41.3 Million - $48.7 Million	-220,351 Reduced 4.89%	4,288,458 $865 Million
Q1 2021 May 17, 2021	BUY	$207.02 - $241.31 $70.9 Million - $82.6 Million	342,275 Added 8.21%	4,508,809 $969 Million
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $469 Million - $626 Million	2,265,577 Added 119.18%	4,166,534 $985 Million
Q3 2020 Nov 16, 2020	SELL	$255.65 - $303.1 $15.9 Million - $18.9 Million	-62,356 Reduced 3.18%	1,900,957 $517 Million
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $20.7 Million - $27.1 Million	91,678 Added 4.9%	1,963,313 $570 Million
Q1 2020 May 14, 2020	SELL	$199.77 - $247.81 $52.6 Million - $65.2 Million	-263,221 Reduced 12.33%	1,871,635 $445 Million
Q4 2019 Feb 18, 2020	BUY	$166.71 - $223.91 $43.8 Million - $58.8 Million	262,589 Added 14.03%	2,134,856 $467 Million
Q3 2019 Nov 14, 2019	BUY	$166.23 - $187.09 $137 Million - $154 Million	822,331 Added 78.32%	1,872,267 $317 Million
Q2 2019 Jul 31, 2019	BUY	$164.61 - $190.37 $46.7 Million - $54 Million	283,447 Added 36.98%	1,049,936 $193 Million
Q1 2019 Apr 30, 2019	SELL	$163.73 - $194.7 $18.7 Million - $22.2 Million	-114,085 Reduced 12.96%	766,489 $141 Million
Q4 2018 Feb 06, 2019	BUY	$151.91 - $192.21 $55.6 Million - $70.4 Million	366,207 Added 71.2%	880,574 $146 Million
Q3 2018 Nov 09, 2018	SELL	$167.73 - $192.74 $50.4 Million - $57.9 Million	-300,420 Reduced 36.87%	514,367 $99.1 Million
Q2 2018 Aug 10, 2018	SELL	$145.72 - $169.96 $5.46 Million - $6.37 Million	-37,454 Reduced 4.39%	814,787 $138 Million
Q1 2018 May 14, 2018	SELL	$151.6 - $177.13 $48.4 Million - $56.5 Million	-319,130 Reduced 27.24%	852,241 $139 Million
Q4 2017 Feb 09, 2018	BUY	$137.28 - $155.55 $79.6 Million - $90.1 Million	579,501 Added 97.91%	1,171,371 $176 Million
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $21.2 Million - $23.2 Million	142,895 Added 31.83%	591,870 $0
Q2 2017 Aug 17, 2017	BUY	N/A	448,975	448,975 $57.9 Million

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Vertex Pharmaceuticals Inc Transaction History